News

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...
3 MILFORD, Mass., May 28, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the launch of the BioResolve Protein A Affinity Columns with MaxPeak Premier Technology, providing ...
Biotechnology company kyron.bio today announced a €5.5 million funding round to solve these issues using precise control of sugar molecules found on the surface of a drug - also known as glycans.
Biotechnology company kyron.bio today announced a €5.5 million funding round to solve these issues using precise control of sugar molecules found on the surface of a drug - also known as glycans. The ...
“This investigational therapy has the potential to address an important unmet need in patients with checkpoint inhibitor-refractory advanced cancers,” said Dr. Piha-Paul. “We’re observing systemic ...
We have worked to incorporate such protein–protein contacts into our design and selection strategies for short peptide extensions that promote cooperative binding of zinc finger proteins to DNA.
LXW7 is a disulfide cyclic octa-peptide (cGRGDdvc) containing unnatural amino acids flanking both sides of the main functional motif; therefore it will be more resistant to proteolysis and more stable ...